Laboratorios Farmaceuticos ROVI (ROVI) — Strategic Asset Allocation Index
Laboratorios Farmaceuticos ROVI (ROVI) has a Strategic Asset Allocation Index of 40.9% as of September 2023. Strategic assets (PP&E of €226.66 Million plus long-term investments of €-) total €226.66 Million, measured against net assets of €554.64 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See ROVI equity to assets ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Laboratorios Farmaceuticos ROVI Strategic Asset Allocation Index (2003–2022)
This chart shows how Laboratorios Farmaceuticos ROVI's Strategic Asset Allocation Index has evolved across 20 annual periods from 2003 to 2022. As of September 2023, the index stands at 40.9%, representing strategic assets of €226.66 Million against net assets of €554.64 Million EUR. For live market cap and overall valuation, see Laboratorios Farmaceuticos ROVI stock valuation.
Annual Strategic Asset Allocation Index for Laboratorios Farmaceuticos ROVI (2003–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Laboratorios Farmaceuticos ROVI from 2003 to 2022, covering 20 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See ROVI net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 41.3% | €215.54 Million | €215.54 Million | €- | €521.38 Million | ▲ +2.7 pp |
| 2021 | 38.6% | €181.78 Million | €181.78 Million | €- | €470.98 Million | ▼ -3.0 pp |
| 2020 | 41.6% | €155.40 Million | €155.40 Million | €- | €373.70 Million | ▲ +0.2 pp |
| 2019 | 41.4% | €133.52 Million | €131.61 Million | €1.91 Million | €322.39 Million | ▲ +7.3 pp |
| 2018 | 34.1% | €97.94 Million | €95.84 Million | €2.11 Million | €287.47 Million | ▼ -13.5 pp |
| 2017 | 47.6% | €91.18 Million | €89.06 Million | €2.12 Million | €191.69 Million | ▲ +1.0 pp |
| 2016 | 46.6% | €85.46 Million | €82.82 Million | €2.64 Million | €183.41 Million | ▼ -3.1 pp |
| 2015 | 49.7% | €81.87 Million | €81.80 Million | €70.00K | €164.78 Million | ▲ +3.2 pp |
| 2014 | 46.5% | €73.66 Million | €73.59 Million | €71.00K | €158.47 Million | ▼ -6.3 pp |
| 2013 | 52.8% | €76.32 Million | €60.20 Million | €16.12 Million | €144.46 Million | ▲ +10.3 pp |
| 2012 | 42.5% | €53.79 Million | €53.79 Million | €- | €126.45 Million | ▲ +2.3 pp |
| 2011 | 40.2% | €45.86 Million | €45.86 Million | €- | €113.98 Million | ▼ -0.7 pp |
| 2010 | 41.0% | €42.66 Million | €42.66 Million | €- | €104.13 Million | ▼ -4.5 pp |
| 2009 | 45.5% | €32.54 Million | €32.54 Million | €- | €71.50 Million | ▼ -16.0 pp |
| 2008 | 61.6% | €29.82 Million | €29.82 Million | €- | €48.44 Million | ▲ +20.0 pp |
| 2007 | 41.6% | €21.58 Million | €21.58 Million | €- | €51.92 Million | ▼ -12.8 pp |
| 2006 | 54.4% | €14.03 Million | €14.03 Million | €- | €25.81 Million | ▲ +54.4 pp |
| 2005 | 0.0% | €11.33 Million | €11.33 Million | €- | €4.80 Trillion | ▼ -100.9 pp |
| 2004 | 100.9% | €2.94 Million | €2.94 Million | €- | €2.92 Million | ▲ +82.9 pp |
| 2003 | 18.0% | €3.21 Million | €3.21 Million | €- | €17.80 Million | — |